RFA-Announcement of a Limited Competition for the Continuation of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (U01)
The summary for the RFA-Announcement of a Limited Competition for the Continuation of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
RFA-Announcement of a Limited Competition for the Continuation of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (U01): This is an announcement for a Limited Competition to solicit a single grant application from the Principal Investigator whose institution is currently serving as the Operations Center for the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. This Limited Competition will provide support for five years to Clinical Centers to continue recruitment, treatment, and follow-up of study participants enrolled in the trial. Support will also be provided for the Data Coordinating Center, the Central Laboratory, the Endpoint Adjudication Center, and the Operations Center.
|Federal Grant Title:||RFA-Announcement of a Limited Competition for the Continuation of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (U01)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-DK-06-502|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Kidney Diseases, Urology and Hematology Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Jul 26, 2006|
|Posted Date:||May 31, 2006|
|Creation Date:||May 31, 2006|
|Archive Date:||Aug 25, 2006|
|Total Program Funding:||$19,500,000|
|Maximum Federal Grant Award:||$3,900,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:||1|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. -You may submit a grant application if your organization received a Notice of Grant Award (U01 DK61700) for the FAVORIT Trial. -The objective of the continuation of the FAVORIT Trial is to complete recruitment and to continue intervention and follow-up of the enrolled study participants. Therefore, the single applicant for this RFA should be the organizations which served as the Operations Center, the Data Coordinating Center, the Central Laboratory, and the Endpoint Adjudication Center during the previous project period.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • Investigations on Primary Immunodeficiency Diseases (R01)
- • Grants for Basic Research in Glomerular Diseases (R01)
- • Advances in Polycystic Kidney Disease (R01)
- • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
- • Calcium Oxalate Stone Diseases (R01)
- • Research Grants for Clinical Studies of Kidney Diseases
- • Chronic Prostatitis Collaborative Research Network (Cpcrn)
- • Frequent Hemodialysis Clinical Trials
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...